However, if meconium is passed prematurely due to fetal distress, it can lead to serious complications such as respiratory distress and low Apgar scores.
This case study will examine the presentation of an infant with meconium aspiration syndrome, detailing the diagnostic process and treatment strategies for managing this potentially life-threatening condition.
Take our free course to master essential pathology concepts with TMC/CSE exam tips and helpful practice questions.
Meconium Aspiration Syndrome Clinical Scenario
You are called to the operating room for the delivery of a post-term infant born to a 29-year-old primigravida with no known health conditions. The mother does not smoke or drink and has received routine prenatal care. Labor was induced due to lack of progression and fetal distress, indicated by decelerations. Prenatal ultrasounds and laboratory work showed no signs of fetal abnormalities during the pregnancy.
Diagnosis
Consider Meconium Aspiration Syndrome (MAS) because post-term delivery and fetal distress are risk factors. Diagnosis requires meconium exposure, respiratory distress, compatible chest imaging, and assessment for other causes. Fetal distress and hypoxemia in utero are commonly associated with increased peristalsis and relaxation of the anal sphincter, which can cause the fetus to pass its first bowel movement—meconium—into the amniotic fluid.
When meconium is present in the amniotic fluid, it poses a risk if inhaled by the fetus. Fetal breathing movements occur in utero and move fluid through the airways. However, a distressed or hypoxic fetus may begin gasping, leading to deeper breaths that draw the meconium-stained amniotic fluid past the glottis and into the airways.
Aspirated meconium can obstruct airways and trigger chemical inflammation and surfactant dysfunction, causing serious respiratory complications after birth.
How to Identify Meconium Aspiration Syndrome
During delivery, listen for the physician to call out either “fluid stained” or “fluid clear.” When a physician says “fluid stained,” it indicates that meconium was present in the amniotic fluid.
While the presence of meconium does not always mean the infant has aspirated it, close monitoring is required for signs of MAS in the newborn.
Primary Risk Factor for MAS
Meconium Aspiration Syndrome mainly affects term and post-term infants. Meconium passage becomes more common as gestation advances.
Post-term infants (born at or after 42 weeks) are at the highest risk for MAS, as the likelihood of fetal distress and meconium passage increases with prolonged gestation.
Complications of Meconium Aspiration Syndrome
Meconium Aspiration Syndrome (MAS) can lead to several serious respiratory complications in newborns, including:
- Chemical pneumonitis: This occurs when the lungs become inflamed due to the presence of meconium. It is characterized by atelectasis (lung collapse) and increased production of bronchial secretions. Chemical inflammation does not by itself establish bacterial infection.
- Surfactant dysfunction: Meconium can inactivate surfactant, worsening lung compliance and gas exchange. This differs from primary Respiratory distress syndrome (RDS), which is usually associated with prematurity.
- Upper airway obstruction: Meconium’s thick, sticky consistency can lead to obstruction of the upper airway, preventing the newborn from breathing effectively.
- Alveolar hyperinflation, pneumomediastinum, and pneumothorax: If meconium becomes lodged in the lower airways, it can create a partial obstruction known as a ball-valve effect. This allows the infant to inhale air but prevents complete exhalation, leading to air trapping, which may result in alveolar hyperinflation, pneumomediastinum (air in the chest cavity), or pneumothorax (collapsed lung).
- Atelectasis: Complete airway obstruction by meconium can cause alveolar collapse (atelectasis), reducing the amount of oxygen that reaches the bloodstream and leading to severe respiratory complications.
Note: Recognizing and addressing these complications promptly is essential for improving outcomes in infants affected by MAS.
MAS Scenario: Continued
During a C-section, the doctor announces that the amniotic fluid is stained, raising suspicion of Meconium Aspiration Syndrome (MAS).
Assess for the following findings. Respiratory signs are typical of MAS; abnormal blood pressure or fever requires separate evaluation.
HEENT
- Nasal flaring: A sign of respiratory distress, indicating increased work of breathing.
- Central cyanosis: A sign of hypoxia, where the skin, lips, or tongue may appear bluish.
- Expiratory grunting: The infant’s attempt to create intrinsic PEEP (positive end-expiratory pressure) to help open their airways.
- Retractions: Visible pulling in of the chest muscles, a common sign of respiratory distress.
- See-saw breathing: A pattern of breathing where the chest and abdomen move in opposite directions, indicative of severe respiratory distress.
- Stained skin: Brown or yellow staining on the skin, a hallmark of meconium presence.
- Increased anterior-posterior diameter: Suggests air trapping in the lungs.
- Wheezing or crackles on auscultation: Signs of airway obstruction due to fluid or meconium in the airways.
- Signs of post-term birth: Including the presence of longer nails and wrinkled skin, common in post-term infants.
Vital Signs
- Tachypnea: Rapid breathing, a sign of respiratory distress.
- Tachycardia: Increased heart rate, often seen in response to hypoxia.
- Hypertension: Elevated blood pressure, which may result from stress or hypoxia.
- Fever: The infant may present with fever due to infection or other complications related to MAS.
Radiological Findings
On chest x-rays, you may observe:
- Patchy, irregular densities: Common in MAS, indicating areas of atelectasis or consolidation.
- Increased hyperlucency: Associated with air trapping.
- Hyperinflation: Overexpansion of the lungs due to trapped air.
- Pneumothorax: Air leakage into the pleural space, causing lung collapse.
- Pneumomediastinum: Air present in the mediastinum, the central chest cavity, due to alveolar rupture.
Additional Information: Moments After Birth
If the infant has no respiratory effort after birth, promptly assess breathing and heart rate, regardless of skin color or meconium staining.
Follow the neonatal resuscitation sequence:
- Provide warmth, dry, position the airway, and briefly stimulate if needed.
- Begin positive pressure ventilation (PPV) within 60 seconds after birth for apnea, gasping, or a heart rate below 100/min despite initial steps.
Note: Do not delay ventilation for routine suction, even with meconium-stained fluid. Suction the airway only when obstruction is suspected; tracheal suction may help if obstruction prevents effective ventilation. See the 2025 AHA/AAP neonatal resuscitation guidance.
Treatment
After appropriate initial stabilization and ventilatory support, the infant is now breathing independently but continues to show signs of hypoxia, tachypnea, tachycardia, nasal flaring, and grunting, with an APGAR score of 7.
Recommended Intervention
For persistent distress with spontaneous breathing, monitor preductal oxygen saturation and titrate oxygen. The neonatal team may consider CPAP; its benefit in term infants is uncertain, and pneumothorax risk may increase.
- CPAP supports lung expansion but does not replace ventilation for apnea or gasping.
- Persistent grunting and respiratory distress require reassessment and escalation of support when needed.
Other Treatment Methods
- Bronchopulmonary hygiene: Individualize secretion management. Suction only when secretions obstruct the airway or interfere with ventilation; avoid unnecessary handling.
- Mechanical ventilation: If the infant shows signs of respiratory failure, mechanical ventilation may be necessary. In this case, a ventilator mode with a long expiratory time is preferred to prevent air trapping, a common complication in MAS.
- Antibiotics: May be started while suspected neonatal sepsis or pneumonia is evaluated. Reassess when infection is excluded; meconium exposure alone does not establish a need for prophylaxis.
- Surfactant replacement therapy: May be considered by the neonatal team in selected infants with significant MAS to counteract surfactant inactivation and improve lung function.
- Nitric oxide: Inhaled nitric oxide may be used for hypoxemic respiratory failure with persistent pulmonary hypertension despite optimized oxygenation and ventilation, ideally after echocardiographic confirmation.
- Extracorporeal Membrane Oxygenation (ECMO): In severe cases where other treatment methods fail, ECMO may be considered. ECMO provides prolonged respiratory and cardiac support, allowing the lungs time to recover while bypassing the usual gas exchange processes.
Note: By implementing these treatments, the infant’s respiratory function can be supported, and the risk of further complications associated with Meconium Aspiration Syndrome can be reduced.
Final Thoughts
Meconium Aspiration Syndrome (MAS) is a serious condition that can lead to significant respiratory complications in newborns. Early recognition and prompt intervention are crucial to improving outcomes.
As seen in this case study, careful management, including timely ventilation when needed and individualized respiratory support, can help stabilize infants affected by MAS. With appropriate care, many newborns can recover fully and avoid long-term complications.
Understanding the signs of respiratory distress and employing timely, targeted interventions are essential for healthcare providers managing cases of MAS.
Written by:
John Landry is a registered respiratory therapist from Memphis, TN, and has a bachelor's degree in kinesiology. He enjoys using evidence-based research to help others breathe easier and live a healthier life.
References
- Syad, Edouard, and Manuel Silva- Carmona. “Meconium Aspiration.” National Library of Medicine, StatPearls Publishing, Feb. 2022.
- Monfredini, Chiara, et al. “Meconium Aspiration Syndrome: A Narrative Review.” National Library of Medicine, Children (Basel), Mar. 2021.


